Search - tctmd.com

Displaying 341 - 360 of 1291

Sort: Relevancy | Date

Presentation TCT 2024

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Presenter: Santiago Garcia

October 28, 2024

Presentation TCT 2024

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Presenter: Raj Makkar

October 28, 2024

Presentation TCT 2024

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

Presenter: Manasa Jasti

October 28, 2024

Presentation TCT 2024

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

Presenter: Roland Schmieder

October 28, 2024

Presentation TCT 2024

TCT 513: Clinical Impact and Diagnostic Performance of Photon-Counting Detector Computed Tomography in Coronary Artery Disease

Presenter: Koshiro Sakai

October 28, 2024

Presentation TCT 2024

TCT 484: Twelve Week Safety and Efficacy of a Novel Extravascular Bi-lateral Renal Denervation Device in a Porcine Model at Nominal Dose

Presenter: Abraham Tzafriri

October 28, 2024

Presentation TCT 2024

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

Presenter: Karl Fengler

October 28, 2024

Presentation TCT 2024

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

Presenter: Daria Feshchenko

October 28, 2024

Presentation TCT 2024

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

Chronic Aortic Regurgitation: Have the Society Guidelines Fallen Behind Clinical Practice?

Presenter: Robert Bonow

October 28, 2024

Presentation TCT 2024

TCT 418: Efficacy and Safety of the Bioabsorbable Polymer Everolimus-Eluting Stent in Routine Clinical Practice: Data From the IRIS-DES Registry

Presenter: Kyeong-Won Seo

October 28, 2024

Presentation TCT 2024

TCT 343: Long-Term Clinical Outcomes Following Intravascular Lithotripsy for Severe Coronary Artery Calcification in a Real-World Setting: A 12-Month Follow-Up From the REPLICA-EPIC18 Study

Presenter: Armando Perez de Prado

October 28, 2024

Presentation TCT 2024

TCT 419: Comparative Clinical Outcomes of Amphilimus-Eluting Stents in Diabetic Versus Non-Diabetic Patients

Presenter: Subin Lim

October 28, 2024

Presentation TCT 2024

TCT 392: Impact of Drug-Eluting Stent Eccentricity on Clinical Outcomes After Rotational Atherectomy for Calcified Coronary Artery

Presenter: Hisanori Yui

October 28, 2024

Presentation TCT 2024

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Presenter: Juan F. Iglesias

October 28, 2024

Presentation TCT 2024

Case Examples and Outcomes

Presenter: Tai Kobayashi

October 28, 2024

Presentation TCT 2024

The Body of Evidence: Safety, Efficacy and Sustainability of rf RDN

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

RDN Care Pathway Development

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Setting the Standard: Patient Selection &the Safe and Effective Use of RDN

Presenter: Tai Kobayashi

October 28, 2024

Advertisement

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

TCT 513: Clinical Impact and Diagnostic Performance of Photon-Counting Detector Computed Tomography in Coronary Artery Disease

TCT 484: Twelve Week Safety and Efficacy of a Novel Extravascular Bi-lateral Renal Denervation Device in a Porcine Model at Nominal Dose

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

Chronic Aortic Regurgitation: Have the Society Guidelines Fallen Behind Clinical Practice?

TCT 418: Efficacy and Safety of the Bioabsorbable Polymer Everolimus-Eluting Stent in Routine Clinical Practice: Data From the IRIS-DES Registry

TCT 343: Long-Term Clinical Outcomes Following Intravascular Lithotripsy for Severe Coronary Artery Calcification in a Real-World Setting: A 12-Month Follow-Up From the REPLICA-EPIC18 Study

TCT 419: Comparative Clinical Outcomes of Amphilimus-Eluting Stents in Diabetic Versus Non-Diabetic Patients

TCT 392: Impact of Drug-Eluting Stent Eccentricity on Clinical Outcomes After Rotational Atherectomy for Calcified Coronary Artery

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Case Examples and Outcomes

The Body of Evidence: Safety, Efficacy and Sustainability of rf RDN

RDN Care Pathway Development

Setting the Standard: Patient Selection &the Safe and Effective Use of RDN

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content